A critical role for gelsolin in ventilator-induced lung injury

American Journal of Respiratory Cell and Molecular Biology

Volumn 41, Issue 4, 2009, Pages 426-432

  Maniatis, Nikolaos A ^a   Harokopos, Vaggelis ^c   Thanassopoulou, Artemis ^c   Oikonomou, Nikos ^c   Mersinias, Vassilis ^c   Witke, Walter ^d   Orfanos, Stylianos E ^a   Armaganidis, Apostolos ^a   Roussos, Charalambos ^a,b   Kotanidou, Anastasia ^a,b   Aidinis, Vassilis ^c  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c Institute of Immunology   (Greece)

^d EUROPEAN MOLECULAR BIOLOGY LABORATORY EMBL   (Italy)

Author keywords

Epithelial apoptosis; Gelsolin; Neutrophil infiltration; Ventilator induced lung injury

Indexed keywords

BLEOMYCIN; CYTOKINE; GELSOLIN; LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; IMMUNOCYTOCHEMISTRY; LUNG EDEMA; LUNG INJURY; LUNG LAVAGE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TIDAL VOLUME; UPREGULATION; WILD TYPE;

AIRWAY RESISTANCE; ANIMALS; APOPTOSIS; BRONCHOALVEOLAR LAVAGE FLUID; CAPILLARY PERMEABILITY; CYTOKINES; GELSOLIN; HIGH-FREQUENCY VENTILATION; LUNG; LUNG COMPLIANCE; MICE; MICE, KNOCKOUT; NEUTROPHILS; PULMONARY EDEMA; STRESS, MECHANICAL; VENTILATOR-INDUCED LUNG INJURY;

MUS;

EID: 70349115607     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2008-0144OC     Document Type: Article

References (49)

1. dos Santos CC, Slutsky AS. The contribution of biophysical lung injury to the development of biotrauma. Annu Rev Physiol 2006;68:585-618.
2. Frank JA, Matthay MA. Science review: mechanisms of ventilator-induced injury. Crit Care 2003;7:233-241. (Pubitemid 36748885)
3. Pinhu L, Whitehead T, Evans T, Griffiths M. Ventilator-associated lung injury. Lancet 2003;361:332-340.
4. Gourlay CW, Ayscough KR. The actin cytoskeleton: a key regulator of apoptosis and ageing? Nat Rev Mol Cell Biol 2005;6:583-589.
5. Ingber DE. Tensegrity: the architectural basis of cellular mechanotransduction. Annu Rev Physiol 1997;59:575-599.
6. Dos Remedios CG, Chhabra D, Kekic MI, Dedova V, Tsubakihara M, Berry DA, Nosworthy NJ. Actin binding proteins: regulation of cytoskeletal microfilaments. Physiol Rev 2002;83:433-473.
7. Kwiatkowski DJ. Functions of gelsolin: motility, signaling, apoptosis, cancer. Curr Opin Cell Biol 1999;11:103-108.
8. Kothakota S, Azuma T, Reinhard C, Klippel A, Tang J, Chu K, McGarry TJ, Kirschner MW, Koths K, Kwiatkowski DJ, et al. Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science 1997;278:294-298. (Pubitemid 27450877)
9. Hengartner MO. The biochemistry of apoptosis. Nature 2000;407:770-776.
10. Oikonomou N, Thanasopoulou A, Tzouvelekis A, Harokopos V, Paparountas T, Nikitopoulou I, Witke W, Karameris A, Kotanidou A, Bouros D, et al. Gelsolin expression is necessary for the development of pulmonary inflammation and fibrosis. Thorax 2009;64:467-475.
11. Martin TR, Hagimoto N, Nakamura M, Matute-Bello G. Apoptosis and epithelial injury in the lungs. Proc Am Thorac Soc 2005;2:214-220.
12. Abraham E. Neutrophils and acute lung injury. Crit Care Med 2003;31:S195-S199.
13. Aidinis V, Carninci P, Armaka M, Witke W, Harokopos V, Pavelka N, Koczan D, Argyropoulos C, Thwin MM, Moller S, et al. Cytoskeletal rearrangements in synovial fibroblasts as a novel pathophysiological determinant of modeled rheumatoid arthritis. PLoS Genet 2005;1:e48.
14. Tzouvelekis A, Harokopos V, Paparountas T, Oikonomou N, Chatziioannou A, Vilaras G, Tsiambas E, Karameris A, Bouros D, Aidinis V. Pulmonary fibrosis comparative expression profiling suggests key role of hypoxia inducible factor 1a. Am J Respir Crit Care Med 2007;176:1108-1119.
15. Christofidou-Solomidou M, Scherpereel A, Solomides CC, Muzykantov VR, Machtay M, Albelda SM, DiNubile MJ. Changes in plasma gelsolin concentration during acute oxidant lung injury in mice. Lung 2002;180:91-104. (Pubitemid 35477918)
16. Lee PS, Waxman AB, Cotich KL, Chung SW, Perrella MA, Stossel TP. Plasma gelsolin is a marker and therapeutic agent in animal sepsis. Crit Care Med 2007;35:849-855.
17. Mounzer KC, Moncure M, Smith YR, Dinubile MJ. Relationship of admission plasma gelsolin levels to clinical outcomes in patients after major trauma. Am J Respir Crit Care Med 1999;160:1673-1681.
18. Witke W, Sharpe AH, Hartwig JH, Azuma T, Stossel TP, Kwiatkowski DJ. Hemostatic, inflammatory, and fibroblast responses are blunted in mice lacking gelsolin. Cell 1995;81:41-51.
19. Oikonomou N, Harokopos V, Zalezsky J, Valavanis C, Kotanidou A, Szymkowski DE, Kollias G, Aidinis V. Soluble TNF mediates the transition from pulmonary inflamation to pulmonary fibrosis. PLoS One 2006;1:e108.
20. Kotanidou A, Loutrari H, Papadomichelakis E, Glynos C, Magkou C, Armaganidis A, Papapetropoulos A, Roussos C, Orfanos SE. Inhaled activated protein C attenuates lung injury induced by aerosolized endotoxin in mice. Vascul Pharmacol 2006;45:134-140. (Pubitemid 44374413)
21. Allen GB, Pavone LA, DiRocco JD, Bates JH, Nieman GF. Pulmonary impedance and alveolar instability during injurious ventilation in rats. J Appl Physiol 2005;99:723-730.
22. Becker PM, Kazi AA, Wadgaonkar R, Pearse DB, Kwiatkowski DJ, Garcia JG. Pulmonary vascular permeability and ischemic injury in gelsolin-deficient mice. Am J Respir Cell Mol Biol 2003;28:478-484. (Pubitemid 36399370)
23. Kobayashi Y. Neutrophil infiltration and chemokines. Crit Rev Immunol 2006;26:307-316.
24. Halbertsma FJ, Vaneker M, Scheffer GJ, van der Hoeven JG. Cytokines and biotrauma in ventilator-induced lung injury: a critical review of the literature. Neth J Med 2005;63:382-392. (Pubitemid 41723236)
25. Dolinay T, Wu W, Kaminski N, Ifedigbo E, Kaynar AM, Szilasi M, Watkins SC, Ryter SW, Hoetzel A, Choi AM. Mitogen-activated protein kinases regulate susceptibility to ventilator-induced lung injury. PLoS One 2008;3:e1601. (Pubitemid 351850584)
26. Le A, Damico R, Damarla M, Boueiz A, Pae HH, Skirball J, Hasan E, Peng X, Chesley A, Crow MT, et al. Alveolar cell apoptosis is dependent on p38 MAP kinase-mediated activation of xanthine oxidoreductase in ventilator-induced lung injury. J Appl Physiol 2008;105:1282-1290.
27. Li LF, Liao SK, Ko YS, Lee CH, Quinn DA. Hyperoxia increases ventilator-induced lung injury via mitogen-activated protein kinases: a prospective, controlled animal experiment. Crit Care 2007;11:R25.
28. Syrkina O, Jafari B, Hales CA, Quinn DA. Oxidant stress mediates inflammation and apoptosis in ventilator-induced lung injury. Respirology 2008;13:333-340.
29. Vaschetto R, Kuiper JW, Chiang SR, Haitsma JJ, Juco JW, Uhlig S, Plotz FB, Della Corte F, Zhang H, Slutsky AS. Inhibition of poly(adenosine diphosphate-ribose) polymerase attenuates ventilator- induced lung injury. Anesthesiology 2008;108:261-268. (Pubitemid 351156736)
30. Martin TR, Nakamura M, Matute-Bello G. The role of apoptosis in acute lung injury. Crit Care Med 2003;31:S184-S188. (Pubitemid 36458165)
31. Jiang JS, Wang LF, Chou HC, Chen CM. Angiotensin-converting enzyme inhibitor captopril attenuates ventilator-induced lung injury in rats. J Appl Physiol 2007;102:2098-2103. (Pubitemid 47080739)
32. Henson PM, Tuder RM. Apoptosis in the lung: induction, clearance and detection. Am J Physiol Lung Cell Mol Physiol 2008;294:L601-L611.
33. Fischer U, Janicke RU, Schulze-Osthoff K. Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ 2003;10:76-100. (Pubitemid 36511834)
34. Koh DW, Dawson TM, Dawson VL. Mediation of cell death by poly(ADP-ribose) polymerase-1. Pharmacol Res 2005;52:5-14.
35. Oliver FJ, Menissier-de Murcia J, de Murcia G. Poly(ADP-ribose) polymerase in the cellular response to DNA damage, apoptosis, and disease. Am J Hum Genet 1999;64:1282-1288. (Pubitemid 30468745)
36. Cooper JA, Bryan J, Schwab BR, Frieden C, Loftus DJ, Elson EL. Microinjection of gelsolin into living cells. JCell Biol 1987;104:491-501.
37. Geng YJ, Azuma T, Tang JX, Hartwig JH, Muszynski M, Wu Q, Libby P, Kwiatkowski DJ. Caspase-3-induced gelsolin fragmentation contributes to actin cytoskeletal collapse, nucleolysis, and apoptosis of vascular smooth muscle cells exposed to proinflammatory cytokines. Eur J Cell Biol 1998;77:294-302. (Pubitemid 29017163)
38. Chhabra D, Nosworthy NJ, dos Remedios CG. The N-terminal fragment of gelsolin inhibits the interaction of DNase I with isolated actin, but not with the cofilin-actin complex. Proteomics 2005;5:3131-3136.
39. Davoodian K, Ritchings BW, Ramphal R, Bubb MR. Gelsolin activates DNase I in vitro and cystic fibrosis sputum. Biochemistry 1997;36:9637-9641. (Pubitemid 27364673)
40. Tang PS, Mura M, Seth R, Liu M. Acute lung injury and cell death: how many ways can cells die? Am J Physiol Lung Cell Mol Physiol 2008;294:L632-L641.
41. Belperio JA, Keane MP, Burdick MD, Londhe V, Xue YY, Li K, Phillips RJ, Strieter RM. Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury. J Clin Invest 2002;110:1703-1716. (Pubitemid 35424249)
42. Choudhury S, Wilson MR, Goddard ME, O'Dea KP, Takata M. Mechanisms of early pulmonary neutrophil sequestration in ventilator- induced lung injury in mice. Am J Physiol Lung Cell Mol Physiol 2004;287:L902-L910. (Pubitemid 39391019)
43. Karzai W, Cui X, Heinicke N, Niemann C, Gerstenberger EP, Correa R, Banks S, Mehlhorn B, Bloos F, Reinhart K, et al. Neutrophil stimulation with granulocyte colony-stimulating factor worsens ventilator- induced lung injury and mortality in rats. Anesthesiology 2005;103:996-1005. (Pubitemid 41552055)
44. Kawano T, Mori S, Cybulsky M, Burger R, Ballin A, Cutz E, Bryan AC. Effect of granulocyte depletion in a ventilated surfactant-depleted lung. J Appl Physiol 1987;62:27-33. (Pubitemid 17060592)
45. Yiming MT, Parthasarathi K, Issekutz AC, Bhattacharya S. Sequence of endothelial signaling during lung expansion. Am J Respir Cell Mol Biol 2005;33:549-554. (Pubitemid 41753130)
46. Wen D, Corina K, Chow EP, Miller S, Janmey PA, Pepinsky RB. The plasma and cytoplasmic forms of human gelsolin differ in disulfide structure. Biochemistry 1996;35:9700-9709. (Pubitemid 26302982)
47. Vasconcellos CA, Allen PG, Wohl ME, Drazen JM, Janmey PA, Stossel TP. Reduction in viscosity of cystic fibrosis sputum in vitro by gelsolin. Science 1994;263:969-971.
48. Bucki R, Georges PC, Espinassous Q, Funaki M, Pastore JJ, Chaby R, Janmey PA. Inactivation of endotoxin by human plasma gelsolin. Biochemistry 2005;44:9590-9597. (Pubitemid 40994353)
49. Giganti A, Friederich E. The actin cytoskeleton as a therapeutic target: state of the art and future directions. Prog Cell Cycle Res 2003;5:511-525.